Abstract:This study reports the fabrication of near‐infrared light‐driven and directionally controllable nanomotor (CuSiO3@Au‐Pd) that not only enhances cellular uptake and tumor tissue penetration but also facilitates chemodynamic and photothermal therapy, thereby promoting cell apoptosis. Furthermore, the designed CuSiO3@Au‐Pd can induce the cellular cuproptosis pathway, enabling cuproptosis‐assisted synergistic cancer therapy. Cuproptosis, a newly discovered cell death pathway, has shown great potential in cancer treatment. Herein, near‐infrared (NIR) light‐driven nanomotors (CuSiO3@Au‐Pd NMs) are designed for cuproptosis‐assisted synergistic therapy with autonomous mobility and improved cellular uptake and tumor penetration. Specifically, the released Cu2+ ions from CuSiO3@Au‐Pd NMs can induce the Fenton‐like reaction, leading to the generation of hydroxyl radicals (·OH), accompanied by the depletion of glutathione within the MCF‐7 cells. Additionally, the designed CuSiO3@Au‐Pd NMs also exhibit excellent photothermal effects, which can further promote the production of ·OH, resulting in intensified oxidative stress and cellular apoptosis. Moreover, the enhanced tumor permeation efficiency and cellular uptake of CuSiO3@Au‐Pd NMs via autonomous movement under self‐thermophoretic forces are proved using 2D cellular experiments and 3D multicellular tumor spheroids. The resultant intracellular accumulation of Cu2+ can induce the oligomerization of lipoylated proteins, leading to cuproptosis, along with the mitochondrial dysfunction pathway. More importantly, both in vitro and in vivo experiments show that CuSiO3@Au‐Pd NMs could penetrate deeply into tumors and exhibit great anticancer efficacy through multimodal therapeutic methods. These findings manifest promising potentials of NIR‐powered Cu‐based NMs with high maneuverability for future smart and synergistic cancer therapy.

NIR‐Mediated Cu2O/ Au Nanomotors for Synergistically Treating Hepatoma Carcinoma Cells

Design of Near Infrared Light‐Powered Copper Phyllosilicate Nanomotors for Cuproptosis‐Based Synergistic Cancer Therapy

Synergistic therapeutic effect of nanomotors triggered by Near-infrared light and acidic conditions of tumor

Nanosized Janus AuNR-Pt Motor for Enhancing NIR-II Photoacoustic Imaging of Deep Tumor and Pt 2+ Ion-Based Chemotherapy

NIR-II Light-Actuated Nanomotors for Enhanced Photoimmunotherapy Toward Hepatocellular Carcinoma

NIR-propelled Janus nanomotors for active photoacoustic imaging and synergistic photothermal/chemodynamic therapy

Tlyp-1-conjugated Au-nanorod@SiO(2) Core-Shell Nanoparticles for Tumor-Targeted Drug Delivery and Photothermal Therapy.

NIR‐Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy

Plasmon Enhanced Catalysis-Driven Nanomotors with Autonomous Navigation for Deep Cancer Imaging and Enhanced Radiotherapy

Dual-source Powered Nanomotor with Integrated Functions for Cancer Photo-Theranostics.

A Multifunctional Vanadium-Iron-Oxide Nanoparticle Eradicates Hepatocellular Carcinoma Via Targeting Tumor and Endothelial Cells

NIR‐II Light Powered Asymmetric Hydrogel Nanomotors for Enhanced Immunochemotherapy

Dual source-powered multifunctional Pt/FePc@Mn-MOF spindle-like Janus nanomotors for active CT imaging-guided synergistic photothermal/chemodynamic therapy

Self-Propelled Nanomotor for Cancer Precision Combination Therapy

Temperature‐Sensitive Polymer‐Driven Nanomotors for Enhanced Tumor Penetration and Photothermal Therapy

Bioinspired Jellyfish-like Carbon/Manganese Nanomotors with H2O2 and NIR Light Dual-propulsion for Enhanced Tumor Penetration and Chemodynamic Therapy

Photothermal-accelerated urease-powered human serum albumin nanomotor for rapid and efficient photothermal and photodynamic cancer combination therapy

NIR-II light-powered core-shell prodrug nanomotors enhance cancer therapy through synergistic oxidative stress-photothermo modulation

A diselenide MOF-based nanomotor dual-driven by carbon monoxide and near-infrared-II light for multimodal tumor-targeted therapy

Polyoxometalate‐Nanozyme‐Integrated Nanomotors (pomotors) for Self‐Propulsion‐Promoted Synergistic Photothermal‐Catalytic Tumor Therapy

Light-driven rGO/Cu2 + 1O tubular nanomotor with active targeted drug delivery for combination treatment of cancer cells